Positive implications for battery manufacturers
To say that markets have been unkind to alternative energy equities is an understatement. The sector, as represented by the WilderHill Clean Energy index (ECO index), is down 78% since July 2008 and down 61% since 2011.
Especially with China remaining uncertain
To be sub-managed by ClariVest
Subscription models are an exciting and fast-growing sub-sector in the booming e-commerce market, writes TMT Investments' Alexander Selegenev.
Active and passive categories
The closure of many open-ended property funds for only the second time in their history (we think) is a classic case of irrational investor decision-making, writes Guy Stephens, managing director of Rowan Dartington Signature.
Overuse of antibiotics around the globe has created a worrying increase in resistance to many commonly used drugs, writes Carl Harald Janson, lead manager on the International Biotechnology trust.
One of the key differentiating factors of technology – and why it is such an exciting place to invest – is that it has the power to create new markets. Certainly, this may happen sporadically in retailing, or construction, or oil and gas, but permanent,...
The long-promised robotics revolution has arrived. True, it is not quite what people imagined only a few decades ago. The humanoid automata beloved by science fiction are still at best fringe novelties.
Few opportunities in electricity sector
From both issuers and investors
Deadline of 27 June
Value currently underperforming
High conviction portfolio
Tech not immune from growth concerns
Two hard years for African equities
Biotech has fallen
Tom Delic, assistant fund manager at Seneca Investment Managers explores the demographic trends – from opportunities in tech to wealth management – that are available for investors to take advantage of
Just over a month ago, volatility, as measured by the VIX index was around 26%, the highest reading since the Chinese slowdown scare of last August. The FTSE 100 was plunging, reaching its nadir of 5,500 in the morning of 11 February.
Growth in derivative-based defined return investments
The biotechnology sector has been hit particularly hard by the risk-averse sentiment sweeping through global stock markets and after reaching a high in July 2015, the Nasdaq Biotechnology index shed about one-third of its value.
If you buy the 30-year inflation protected gilt today and hold it to maturity you are guaranteed to lose 24% of your real capital. Where should you put your money instead?